1 / 20

Clinical Research Program Report

Clinical Research Program Report. INCTR Annual Meeting 2005 Melissa Adde, Director Clinical Trials Office. General Description of Program . Main Functions Coordination of Strategy Groups Management of Clinical Research Studies Serve as the Data Center for Clinical Research Studies

hoang
Télécharger la présentation

Clinical Research Program Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Research Program Report INCTR Annual Meeting 2005 Melissa Adde, Director Clinical Trials Office Annual Meeting 2005

  2. General Description of Program • Main Functions • Coordination of Strategy Groups • Management of Clinical Research Studies • Serve as the Data Center for Clinical Research Studies • Provision of Education and Training Related to Clinical Trials • Other Functions • Administration of INCTR Ethical Review Committee • Provision of Data Management Services

  3. Strategy Groups – A Brief Review • Comprised of investigators from countries with limited resources • Disease-specific (African BL, Breast Cancer, Cervical Cancer, Leukemia, Leukemia Study Group of India, Lymphoma, Osteosarcoma, Retinoblastoma) • Determine the role of INCTR in the control of a specific cancer • Design of clinical research studies

  4. On-going Clinical Research Studies • Understanding Problems Faced by Parents of Children with Retinoblastoma Prior to Treatment • The Treatment and Characterization of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults • The Treatment and Characterization of Burkitt’s Lymphoma in Africa • A Retrospective Survey of Presentation Features of Breast Cancer and Risk Factors for Treatment Outcome

  5. Retinoblastoma Study • Survey study of parents of children with retinoblastoma (questionnaire) • Objective: • To identify the factors contributing to delays in diagnosis and obtaining treatment

  6. Retinoblastoma Study • 11 institutions from 8 countries have contributed data to this study • Brazil • Bolivia • Mexico • Nigeria • Zimbabwe • Turkey (2 institutions) • India (3 institutions) • Pakistan

  7. Retinoblastoma Study

  8. Retinoblastoma Study – Summary of Findings • Children from rural areas had higher stages of disease • Older age children had higher stages of disease • Fathers’ education level was associated with St Jude Stage of disease (the lower the education level, the higher the stage) • Lower education levels of fathers were associated with increased time intervals between detection of first symptom and diagnosis

  9. INCTR 02-04 - Objectives • Characterize the pattern of ALL in India (immunophenotype, DNA index, molecular profiling) • Correlate laboratory findings with clinical characteristics • Identify prognostic factors predictive of relapse and survival

  10. INCTR 02-04 – Total 149 Patients

  11. INCTR 02-04 Off-Study Patients

  12. INCTR 02-04 Summary • More intensive than MCP841 • Too soon to evaluate outcome differences with MCP841 • Data monitoring has been introduced • Web-based data entry has been introduced • Study committee comprised of PIs formed which is actively making protocol-related decisions

  13. INCTR 03-06 - Objectives • Characterize the presentation features of African Burkitt Lymphoma • Assess response and survival • Utilizes standard treatment (CTX, VCR, MTX and IT therapy) for Africa • Includes second-line treatment for NR or relapse patients (IFOS, ETOP, ARAC, IT therapy) • Improve data collection and patient follow-up

  14. INCTR 03-06 – Patient Characteristics

  15. INCTR 03-06 – Off-Study Patients

  16. INCTR 03-08 • Retrospective Survey of Female Breast Cancer Patients 1993-2001 • Presentation features • Treatment received • Outcome • Data retrieval is underway in 4 institutions (Peru, Egypt, India, Pakistan)

  17. Studies in Development • African Burkitt Lymphoma • Phase II Study of Depocyte (relapsed CNS disease) • Breast Cancer • Randomized study comparing two neoadjuvant approaches in the management of locally advanced breast cancer • Retinoblastoma • Treatment of extraocular retinoblastoma

  18. Reasons for Delays in Study Development • Requires Group Consensus • Takes time to achieve and compromise is necessary • Requires willingness to work in a group vs independently • Competing Local Issues • Little time to devote to protocol development and writing • Local priorities and projects can take precedence and in some cases prohibit participation • Motivation for Conducting Research Differs

  19. Education and Training in Clinical Research • Protocol-specific Data Manager Training Courses • Indian ALL Study (Nov 2004) • African BL Study (Nov 2005) • Breast Cancer Survey Study (2006) • Introduction to Basic Data Management • Manila Philippines June 2005 • Amman Jordan April 2006

  20. Thank You • PIs and Data Managers involved in on-going and completed studies • David Venzon • Paul Jarosinski • OIA and NCI Liaison Office • INCTR ERC • Julia Challinor • Lolita Lantican • Corinne Claes

More Related